Membranous glomerulonephritis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 9: | Line 9: | ||
* The membranous Glomerulonephritis is a rare disease.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref><ref name="pmid28065518">{{cite journal |vauthors=Cattran DC, Brenchley PE |title=Membranous nephropathy: integrating basic science into improved clinical management |journal=Kidney Int. |volume=91 |issue=3 |pages=566–574 |date=March 2017 |pmid=28065518 |doi=10.1016/j.kint.2016.09.048 |url=}}</ref> | * The membranous Glomerulonephritis is a rare disease.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref><ref name="pmid28065518">{{cite journal |vauthors=Cattran DC, Brenchley PE |title=Membranous nephropathy: integrating basic science into improved clinical management |journal=Kidney Int. |volume=91 |issue=3 |pages=566–574 |date=March 2017 |pmid=28065518 |doi=10.1016/j.kint.2016.09.048 |url=}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref | *The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref> | ||
*In 2002, the incidence of membranous glomerulopathy was estimated to be 27 cases per 100,000 individuals worldwide. | *In 2002, the incidence of membranous glomerulopathy was estimated to be 27 cases per 100,000 individuals worldwide. | ||
Revision as of 03:49, 19 July 2018
|
Membranous glomerulonephritis Microchapters |
|
Differentiating Membranous glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranous glomerulonephritis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Membranous glomerulonephritis epidemiology and demographics |
|
FDA on Membranous glomerulonephritis epidemiology and demographics |
|
CDC on Membranous glomerulonephritis epidemiology and demographics |
|
Membranous glomerulonephritis epidemiology and demographics in the news |
|
Blogs on Membranous glomerulonephritis epidemiology and demographics |
|
Directions to Hospitals Treating Membranous glomerulonephritis |
|
Risk calculators and risk factors for Membranous glomerulonephritis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]
Overview
The incidence rate of membranous glomerulonephritis is 27 per 100.000. The prevalence rate of membranous glomerulonephritis is 690 per 100,000.
Epidemiology and Demographics
Incidence
- The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.[1]
- In 2002, the incidence of membranous glomerulopathy was estimated to be 27 cases per 100,000 individuals worldwide.
Prevalence
- The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.[3][4][5]
- In 2002, the prevalence of [disease name] was estimated to be 690 cases per 100,000 individuals worldwide.
Mortality rate
- In 2001, the incidence of Membranous Glomerulonephritis is approximately 28.5 per 100,000 individuals with a mortality rate of 0.38%.[3][4][5]
- The case-fatality rate/mortality rate of membranous glomerulonephritis is approximately 0.38%
Age
- Patients of all age groups may develop membranous glomerulonephritis.[5]
- The incidence of Membranous Glomerulonephritis increases with age; the median age at diagnosis is 40 years.
- Membranous Glomerulonephritis commonly affects individuals older than 40 years of age.
Race
- membranous glomerulopathy usually affects individuals of the caucasian race and Chinese population.[3] [4]
Gender
Region
Developed Countries
Developing Countries
References
- ↑ 1.0 1.1 McGrogan, A.; Franssen, C. F. M.; de Vries, C. S. (2010). "The incidence of primary glomerulonephritis worldwide: a systematic review of the literature". Nephrology Dialysis Transplantation. 26 (2): 414–430. doi:10.1093/ndt/gfq665. ISSN 0931-0509.
- ↑ Cattran DC, Brenchley PE (March 2017). "Membranous nephropathy: integrating basic science into improved clinical management". Kidney Int. 91 (3): 566–574. doi:10.1016/j.kint.2016.09.048. PMID 28065518.
- ↑ 3.0 3.1 3.2 3.3 3.4 Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF (December 2016). "Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China". J. Am. Soc. Nephrol. 27 (12): 3739–3746. doi:10.1681/ASN.2016010093. PMC 5118492. PMID 27365535.
- ↑ 4.0 4.1 4.2 4.3 4.4 Debiec H, Ronco P (July 2014). "Immunopathogenesis of membranous nephropathy: an update". Semin Immunopathol. 36 (4): 381–97. doi:10.1007/s00281-014-0423-y. PMID 24715030.
- ↑ 5.0 5.1 5.2 Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P (January 2000). "Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study". Am. J. Kidney Dis. 35 (1): 157–65. doi:10.1016/S0272-6386(00)70316-7. PMID 10620560.